Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer
Lin, J.J., Liu, S.V., McCoach, C.E., Zhu, V.W., Tan, A.C., Yoda, S., Peterson, J., Do, A., Prutisto-Chang, K., Dagogo-Jack, I., Sequist, L.V., Wirth, L.J., Lennerz, J.K., Hata, A.N., Mino-Kenudson, M., Nardi, V., Ou, S.-H.I., Tan, D.S.-W., Gainor, J.F.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
Optimizing treatment for patients with anaplastic lymphoma kinase-positive lung cancer
Dagogo-Jack, I, Shaw, A T, Riely, G J
Published in Clinical pharmacology and therapeutics (01.05.2017)
Published in Clinical pharmacology and therapeutics (01.05.2017)
Get more information
Journal Article
Real world cfDNA collection in EGFR-mutant NSCLC
Marcoux, N., Sequist, L.V., Hata, A., Banwait, M., Dagogo-Jack, I., Nagy, R., Lanman, R.B., Muzikansky, A., Digumarthy, S.R., Piotrowska, Z.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study
Lin, J.J., Muzikansky, A., Kennedy, E., Kuberski, H., Stober, L.L., Wanat, A.C., Azzoli, C.G., Lennes, I., Sequist, L.V., Dagogo-Jack, I., Shaw, A.T., Gainor, J.F.
Published in ESMO open (01.02.2022)
Published in ESMO open (01.02.2022)
Get full text
Journal Article
Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer
Gainor, J, Dardaei, L, Yoda, S, Friboulet, L, Leischler, I, Katayama, R, Dagogo-Jack, I, Gadgeel, S, Schultz, K, Singh, M, Chin, E, Parks, M, Lee, D, DiCecca, R.H, Lockerman, E, Huynh, T, Logan, J, Benes, C.H, Engelman, J.A, Shaw, A
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA
Brägelmann, J, Dagogo-Jack, I, El Dinali, M, Stricker, T, Brown, C.D, Zuo, Z, Khattri, A, Keck, M, McNerney, M.E, Longnecker, R, Bieging, K, Kocherginsky, M, Alexander, K, Salgia, R, Lingen, M.W, Vokes, E.E, White, K.P, Cohen, E.E.W, Seiwert, T.Y
Published in Oral oncology (01.06.2013)
Published in Oral oncology (01.06.2013)
Get full text
Journal Article
P2.19-01 First-in-Human Phase 1 Trial of VT3989, a First-in-Class YAP/TEAD Inhibitor in Patients with Advanced Mesothelioma
Yap, T., Desai, J., Dagogo-Jack, I., Millward, M., Kindler, H.L., Tolcher, A.W., Frentzas, S., Body, A.L., Thurston, A., Post, L., Dorr, F.A., Kwiatkowski, D.J.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
P2.04-23 Immune-Related Adverse Events: The Growing Pains of Immunooncology
Mooradian, M., Dagogo-Jack, I., Gainor, J., Reynolds, K.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
713TiP A phase I study of PRT3789, a potent and selective degrader of SMARCA2 in patients with advanced or metastatic solid tumors and a SMARCA4 mutation
Dagogo-Jack, I., Dowlati, A., Guo, R., Awad, M.M., Swalduz, A., Calvo, E., Moreno Garcia, V., Adjei, A.A., Lorusso, P., Punekar, S., Leal, T.A., Yap, T.A., Italiano, A., Novotny, W., Tankersley, C., Rowe, S., Paris, G., Sun, W., Spira, A.I., Besse, B.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
MA16.08 Clinical Utility of Detecting ROS1 Genetic Alterations in Plasma
Dagogo-Jack, I., Nagy, R., Ferris, L., Lin, J., Gainor, J., Lanman, R., Shaw, A.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
EP08.02-116 Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors
Villalona Calero, M., Patnaik, A., Maki, R., O'Neil, B., Abbruzzese, J., Dagogo-Jack, I., Devarakonda, S., Wahlroos, S., Lin, C.-C., Fujiwara, Y., Terbuch, A., Postel-Vinay, S., Goebeler, M.-E., Addeo, A., Prenen, H., Arkenau, T., Sacher, A., Liu, C., Kormany, W., Ahnert, J.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
1346PReal world cfDNA collection in EGFR-mutant NSCLC
Marcoux, N, Sequist, L V, Hata, A, Banwait, M, Dagogo-Jack, I, Nagy, R, Lanman, R B, Muzikansky, A, Digumarthy, S R, Piotrowska, Z
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
421 - Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer
Gainor, J., Dardaei, L., Yoda, S., Friboulet, L., Leischler, I., Katayama, R., Dagogo-Jack, I., Gadgeel, S., Schultz, K., Singh, M., Chin, E., Parks, M., Lee, D., DiCecca, R.H., Lockerman, E., Huynh, T., Logan, J., Benes, C.H., Engelman, J.A., Shaw, A.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
MA 07.07 Clinical Outcomes and ALK Resistance Mutations in ALK+ Non-Small Cell Lung Cancer According to EML4-ALK Variant
Lin, J., Zhu, V., Yoda, S., Yeap, B., Jessop, N., Schrock, A., Dagogo-Jack, I., Gowen, K., Stephens, P.J., Ross, J., Ali, S., Miller, V., Gainor, J., Hata, A., Iafrate, A., Ou, S., Shaw, A.
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article